Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
166 hedge funds and large institutions have $956M invested in Meridian Bioscience Inc in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 67 increasing their positions, 43 reducing their positions, and 15 closing their positions.
601% more call options, than puts
Call options by funds: $505K | Put options by funds: $72K
56% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 43
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
9% more capital invested
Capital invested by funds: $880M → $956M (+$76.4M)
2% more funds holding
Funds holding: 163 → 166 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$11.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.86M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.2M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$3.27M |
| 5 |
WBC
Westpac Banking Corp
Sydney,
Australia
|
+$3.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DRZID
DePrince Race & Zollo Inc (DRZ)
Winter Park,
Florida
|
-$16.6M |
| 2 |
DIA
Denver Investment Advisors
Denver,
Colorado
|
-$13.1M |
| 3 |
CCM
Century Capital Management
Boston,
Massachusetts
|
-$12.4M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$4.54M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.83M |
VIVO Hedge Fund Activity: Q3 2013 in Review
166 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2013, worth a combined $956M — up 8.7% from $880M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new VIVO positions and 15 closed out — a net gain of 4 holders — while 67 added to existing stakes and 43 trimmed.
The largest buyer was Schroder Investment Management Group, adding an estimated $11.3M. The largest seller was DePrince Race & Zollo Inc (DRZ), cutting an estimated $16.6M.
- 166 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2013, up from 163 in Q2 2013.
- Funds reported $956M of Meridian Bioscience Inc stock for Q3 2013, up 8.7% quarter-over-quarter.
- 19 funds opened new Meridian Bioscience Inc positions in Q3 2013 and 15 closed out, a net change of +4 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2013 was Schroder Investment Management Group, an estimated $11.3M added.
- The largest Meridian Bioscience Inc seller in Q3 2013 was DePrince Race & Zollo Inc (DRZ), an estimated $16.6M sold.
Based on aggregated 13F filings for Q3 2013.